Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.36B |
| 2 |
Linde
LIN
|
+$1.24B |
| 3 |
GE Aerospace
GE
|
+$1.08B |
| 4 |
Abbott
ABT
|
+$905M |
| 5 |
American Express
AXP
|
+$851M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$1.84B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.68B |
| 3 |
JPMorgan Chase
JPM
|
+$1.32B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.19B |
| 5 |
Citigroup
C
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.92% |
| 2 | Healthcare | 16.33% |
| 3 | Financials | 15.58% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Ionis Pharmaceuticals
IONS
$9.06B
| $1.11B | 0.15% |
20,509,750
+45,911
| +0.2% | +$2.34M |
|
127
iShares MSCI EAFE ETF
EFA
$78.4B
| $1.11B | 0.15% |
18,852,846
+8,277,894
| +78% | +$517M |
|
128
Alnylam Pharmaceuticals
ALNY
$29.5B
| $1.1B | 0.15% |
15,154,553
+54,637
| +0.4% | +$4.2M |
|
129
Biogen
BIIB
$29.8B
| $1.1B | 0.15% |
3,671,066
-651,121
| -15% | -$208M |
|
130
Philip Morris
PM
$292B
| $1.1B | 0.15% |
16,473,615
-1,300,505
| -7% | -$109M |
|
131
Amdocs
DOX
$5.88B
| $1.07B | 0.15% |
18,209,169
+1,543,698
| +9% | +$96.8M |
|
132
iShares Core S&P 500 ETF
IVV
$884B
| $1.03B | 0.14% |
4,100,274
-2,916,795
| -42% | -$792M |
|
|
CTXS
133
DELISTED
Citrix Systems Inc
CTXS
| $1B | 0.14% |
9,796,045
-399,206
| -4% | -$42.2M |
|
134
BP
BP
$114B
| $986M | 0.14% |
26,826,664
+4,619,429
| +21% | +$184M |
|
135
Sherwin-Williams
SHW
$86B
| $986M | 0.14% |
7,516,236
-3,231,555
| -30% | -$436M |
|
136
Phillips 66
PSX
$82.7B
| $970M | 0.13% |
11,260,757
-3,099,365
| -22% | -$303M |
|
137
Intel
INTC
$459B
| $967M | 0.13% |
20,607,249
-7,224,979
| -26% | -$338M |
|
138
Accenture
ACN
$101B
| $963M | 0.13% |
6,830,316
+2,217,910
| +48% | +$351M |
|
139
Morgan Stanley
MS
$332B
| $960M | 0.13% |
24,202,184
-8,487,898
| -26% | -$370M |
|
140
Huntington Bancshares
HBAN
$35.1B
| $958M | 0.13% |
80,400,701
-1,383,168
| -2% | -$19.2M |
|
141
Stryker
SYK
$131B
| $930M | 0.13% |
5,934,622
+353,028
| +6% | +$59M |
|
142
Neurocrine Biosciences
NBIX
$16.7B
| $930M | 0.13% |
13,016,591
-473,255
| -4% | -$45.3M |
|
|
APC
143
DELISTED
Anadarko Petroleum
APC
| $915M | 0.13% |
20,868,184
+2,251,077
| +12% | +$127M |
|
144
Seagate
STX
$189B
| $913M | 0.13% |
23,656,503
+600,068
| +3% | +$25.3M |
|
145
Equinix
EQIX
$102B
| $907M | 0.12% |
2,571,552
-54,023
| -2% | -$21.1M |
|
146
Lam Research
LRCX
$369B
| $906M | 0.12% |
66,525,310
+31,143,930
| +88% | +$446M |
|
147
American International
AIG
$41.8B
| $902M | 0.12% |
22,895,506
-5,410,274
| -19% | -$236M |
|
148
British American Tobacco
BTI
$128B
| $889M | 0.12% |
27,897,707
-4,197,470
| -13% | -$163M |
|
149
Gilead Sciences
GILD
$163B
| $884M | 0.12% |
14,131,228
-4,079,394
| -22% | -$285M |
|
150
ResMed
RMD
$31.2B
| $871M | 0.12% |
7,644,715
-224,877
| -3% | -$24.1M |
|
Similar funds
Fidelity Investments's Q4 2018 Portfolio in Review
As of Q4 2018, Fidelity Investments held 4,539 positions worth $730B, down 18% from $889B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Fidelity Investments's Q4 2018 filing shows 587 new, 1,369 increased, 1,680 reduced and 332 closed positions. Its largest new stake was Linde: 7,854,665 shares worth $1.25B. The largest sale was Aetna Inc, an estimated $1.84B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Fidelity Investments's largest Q4 2018 buy was Linde: 7,854,665 shares worth $1.25B.
- Fidelity Investments added most to Microsoft in Q4 2018, an estimated $1.36B increase.
- Fidelity Investments's biggest Q4 2018 reduction was Alphabet (Google) Class C, cutting an estimated $1.68B.
- Fidelity Investments fully exited Aetna Inc in Q4 2018, selling an estimated $1.84B.
- Fidelity Investments's ten largest holdings make up 22% of its $730B portfolio in Q4 2018.
- Fidelity Investments opened 587 new positions and closed 332 in Q4 2018.
- Fidelity Investments's portfolio value fell 18% quarter-over-quarter to $730B.
Based on Fidelity Investments's 13F filing for Q4 2018, filed 13 Feb 2019.